The Changing Therapeutic Landscape of Metastatic Renal Cancer

The practising clinician treating a patient with metastatic clear cell renal cell carcinoma (CCRCC) faces a difficult task of choosing the most appropriate therapeutic regimen in a rapidly developing field with recommendations derived from clinical trials. NCCN guidelines for kidney cancer initiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Angulo, Javier C., Shapiro, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770566/
https://www.ncbi.nlm.nih.gov/pubmed/31443471
http://dx.doi.org/10.3390/cancers11091227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770566/
https://www.ncbi.nlm.nih.gov/pubmed/31443471
http://dx.doi.org/10.3390/cancers11091227

Ejemplares similares